Sample size calculation for non-compliance randomized trials with repeated measurements in binary data

Computational Statistics and Data Analysis

Volumn 51, Issue 8, 2007, Pages 3832-3843

  Lui, Kung Jong ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Binary data; Non compliance randomized trials; Power; Repeated measurements; Sample size calculation

Indexed keywords

MATHEMATICAL MODELS; PATIENT TREATMENT; PROBABILITY; RANDOM PROCESSES;

BINARY DATA; NON COMPLIANCE RANDOMIZED TRIALS; RANDOMIZED CLINICAL TRIAL (RCT); REPEATED MEASUREMENTS; SAMPLE SIZE CALCULATION;

DATA STRUCTURES;

EID: 33947624215     PISSN: 01679473     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.csda.2006.02.022     Document Type: Article

References (17)

1. Angrist J.D., Imbens G.W., and Rubin D.B. Identification of causal effects using instrumental variables. Journal of the American Statistical Association 91 (1996) 444-455
2. Bernhard G., and Compagnone D. Binary data in prerandomized designs. Biometrical Journal 31 (1989) 29-33
3. Brunner E., and Neumann N. On the mathematical basis of Zelen's prerandomized designs. Methods of Information in Medicine 24 (1985) 120-130
4. Casella G., and Berger R.L. Statistical Inference (1990), Duxbury, Belmont, California
5. Gillings D., and Koch G. The Application of the principle of intention-to-treat to the analysis of clinical trials. Drug Information Journal 25 (1991) 411-424
6. Lui K.-J. Sample size for repeated measurements in dichotomous data. Statistics in Medicine 10 (1991) 463-472
7. Lui K.-J. Sample size determination for repeated measurements in bioequivalence test. Journal of Pharmacokinetics and Biopharmaceutics 25 (1997) 507-513
8. Lui, K.-J., 2006. Interval estimation of risk difference in non-compliance randomized trials with repeated measurements. (Dept. of Mathematics and Statistics, San Diego State University, San Diego, CA, 2006).
9. Lui K.-J., and Cumberland W.G. Sample size requirement for repeated measurements in continuous data. Statistics in Medicine 11 (1992) 633-641
10. Lui K.-J., and Lin C.-D. Interval estimation of treatment effects in double consent randomized design. Statistica Sinica 13 (2003) 179-187
11. Mark S.D., and Robins J.M. A method for the analysis of randomized trials with compliance information: an application to the Multiple Risk Factor Intervention Trial. Controlled Clinical Trials 14 (1993) 79-97
12. Matsuyama Y. Correcting for non-compliance of repeated binary outcomes in randomized clinical trials: randomized analysis approach. Statistics in Medicine 21 (2002) 675-687
13. Ohno R., Miyawaki S., Hatake K., Kuriyama K., Saito K., Kanamaru A., Kobayashi T., Kodera Y., Nishikawa K., Matsuda S., Yamada O., Omoto E., Takeyama H., Tsukuda K., Asou N., Tamimoto M., Shiozaki H., Tomonaga M., Masaoka T., Miura Y., Takaku F., Ohashi Y., and Motoyoshi K. Human urinary macrophage colony-stimulating Factors reduces the incidence and duration of febrile neutropenia and shortens the period required to finish three courses of intensive consolidation therapy in acute myeloid leukemia: a double-blind controlled study. Journal of Clinical Oncology 15 (1997) 2954-2965
14. Rubin D.B. Bayesian inference for causal effects: the role of randomization. Annals of Statistics 6 (1978) 34-58
15. Sato T. Sample size calculations with compliance information. Statistics in Medicine 19 (2000) 2689-2697
16. Sato T. A method for the analysis of repeated binary outcomes in randomized Clinical trials with non-compliance. Statistics in Medicine 20 (2001) 2761-2774
17. Sommer A., and Zeger S.L. On estimating efficacy from clinical trials. Statistics in Medicine 10 (1991) 45-52